Home Press Releases Primary Cells Market Size Worth $1.79 Billion By 2028 | CAGR: 8.4%

Primary Cells Market Size Worth $1.79 Billion By 2028 | CAGR: 8.4%

The global primary cells market size is expected to reach USD 1.79 billion by 2028 according to a new study by Polaris Market Research. The report “Primary Cells Market Share, Size, Trends, Industry Analysis Report, By Type (Hematopoietic, Hepatocytes, Renal, Gastrointestinal, Skin, Lung); By End-Use (Medical, Pharmaceutical & Biotechnology Companies, Research Institutes); By Source; By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The increasing investments in biomedical research coupled with growth in the occurrence of diseases such as cancer drive the growth of the primary cell culture market. Increasing demand for advanced drug development and testing, growing applications in genetic engineering and virology, and stringent regulations regarding animal testing boost the growth of this market.

 

The significant growth in healthcare and pharmaceutical sectors, technological advancements, and growing use of primary cells in stem cell therapy are some factors expected to provide growth opportunities during the forecast period. The different types of primary cells include hematopoietic, hepatocytes, renal cells, gastrointestinal cells, skin cells, lung cells, and others. There has been a high demand for hematopoietic cells, which are derived from blood and bone marrow.

 

The demand for human primary cells was high in 2019. Human primary cells exhibit the functional and morphological characteristics of their tissue of origin. Human primary cells are increasingly being used in cancer research, and drug discovery. Other applications driving the growth of this segment include 3D cell culture, drug screening, and toxicity testing, monoclonal antibodies, and genetic engineering.

 

Have Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/primary-cells-market/request-for-sample

 

The increasing use of these cells for treatment and research associated with cancer, coupled with technological advancements drives the market growth. Hematopoietic primary cells are increasingly being used in stem cell therapy, vaccine development, and the study of tissue and organ replacement, thereby boosting the growth of this segment.

 

The demand for primary cells has increased from pharmaceutical and biotechnology companies for applications such as research and development, drug discovery, testing of new drugs, cosmetics, and chemicals, and analyzing of maximum permissible dosage of new drugs. The increasing investments in biomedical research, coupled with government initiatives support the growth of this segment.

 

North America dominated the global primary cell culture market in 2020 and is expected to maintain its dominance over the forecast period. Growing advancements in cancer research, significant investment in healthcare services, and the increasing occurrence of cancer-related disorders support market growth in this region. The increasing geriatric population coupled with government initiatives and programs, and emerging healthcare and pharmaceutical sectors fuel growth in this region.

 

Some major market participants include Cell Biologics, Inc., ZenBio, Inc., Stem Cell Technologies, Sigma-Aldrich, Thermo Fisher Scientific, Cureline, American Type Culture Collection, Cell Applications, Inc., Pelobiotech, Merck KGaA, Axol Bioscience Ltd, Promocell, ALLCells, Lonza Group, AG, and Creative Bioarray.

 

Polaris Market Research has segmented the primary cells market report on the basis of source, type, end-use, and region:

Primary Cells Source Outlook (Revenue, USD Million, 2016 – 2028)

  • Animal Primary Cells
  • Human Primary Cells

Primary Cells Type Outlook (Revenue, USD Million, 2016 – 2028)

  • Hematopoietic
  • Hepatocytes
  • Renal Cells
  • Gastrointestinal Cells
  • Skin Cells
  • Lung Cells
  • Others

Primary Cells End-Use Outlook (Revenue, USD Million, 2016 – 2028)

  • Medical
  • Pharmaceutical and Biotechnology Companies
  • Research Institutes
  • Others

Primary Cells Regional Outlook (Revenue, USD Million, 2016 – 2028)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • RoE
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • Colombia
    • RoLATAM
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Israel
    • UAE
    • RoMEA

License and Pricing

Buy Now

Purchase Report Sections

  • Regional analysis
  • Segmentation analysis
  • Industry outlook
  • Competitive landscape
Request for Discount Pricing

Request For Customization

Please specify your research requirement and get customized report


Regional AnalysisSegmentation AnalysisIndustry OutlookCompetitive Analysis
By using this form you agree with the storage and handling of your data by this website.

Speak to Analyst

By using this form you agree with the storage and handling of your data by this website.